naratip

CRVS consolidation

naratip 已更新   
NASDAQ:CRVS   Corvus Pharmaceuticals, Inc.
Consolidation in TF wk is that's all I could say.

Modulating immune system play role in cancer and infection.
In cancer treatment targeted therapy and tailed play major role (High cost of drug of course)

CRVS do the modulating immune system thing

Now let's see what's CRVS do.
What the physicians want is "When can we use this medication/protocol?"
It's phase 3 to use in human before FDA approves

Phase 3 is important when you do research

Here what's they do

COVID
Phase 1 CPI-006 (B cell activation -> immune system thing about white blood cell)

CANCER
Phase 1B-2 Ciforadenant Renal cell, prostate
Phase 1 CPI 818 T-cell lymphoma (white blood cell cancer)
etc.

So the factors that the price will surge are:-
-Positive Research outcome
-Phase 3
-FDA approve

that's all

评论:
higher low
评论:
I sold this junk at January 2021 and never look back again. I bought $SPWR and $SE. I'm glad I've made my right decision.
免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。